Your browser doesn't support javascript.
loading
Stent-assisted coiling of acutely ruptured cerebral aneurysm: a multicenter prospective registry study (SAVE).
Li, Gaozhi; Han, Yongquan; Ding, Shenghao; Pan, Yaohua; Zhang, Xiaohua; Zhao, Bing.
Afiliación
  • Li G; Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Pujian 160 Road, Shanghai, 200217, China.
  • Han Y; Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Pujian 160 Road, Shanghai, 200217, China.
  • Ding S; Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
  • Pan Y; Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Pujian 160 Road, Shanghai, 200217, China.
  • Zhang X; Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Pujian 160 Road, Shanghai, 200217, China.
  • Zhao B; Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Pujian 160 Road, Shanghai, 200217, China.
BMC Neurol ; 22(1): 264, 2022 Jul 18.
Article en En | MEDLINE | ID: mdl-35850667
ABSTRACT

BACKGROUND:

Stent-assisted coiling (SAC) has been reported as a feasible and effective treatment of wide-neck cerebral aneurysms. However, the evidence of SAC of ruptured cerebral aneurysm is lacking. There are no prospective multicenter studies regarding SAC of acutely ruptured aneurysms within 72 hours after subarachnoid hemorrhage. The purpose of the study is to evaluate the safety and efficiency of SAC of acutely ruptured cerebral aneurysms.

METHODS:

This study is a prospective, multicenter, and observation registry of consecutive patients with acutely ruptured cerebral aneurysms treated with SAC. Acutely ruptured aneurysms were confirmed within 72 h after the onset of the syndrome. This study will enroll at least 300 patients in 7 high-volume tertiary hospitals (more than 150 cerebral aneurysms treated per year). The primary outcomes are treatment-related thromboembolic complications within 30 days of the treatment. The secondary outcomes are any hemorrhagic complications and aneurysm recurrence at 6 months of angiographic follow-up. The clinical outcomes are measured with the Modified Rankin Scale (mRS) at discharge and at the 6 months of follow-up. The favorable outcomes are defined as an mRS of grades 0 and 2.

DISCUSSION:

We will perform a prospective, multicenter, and observational registry study of consecutive patients with wide-neck acutely ruptured cerebral aneurysms to improve the safety strategy of SAC of acutely ruptured cerebral aneurysms. TRIAL REGISTRATION Chinese Clinic Trial Registry ChiCTR2000036972 ; Registration date Aug 26, 2020.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aneurisma Intracraneal / Aneurisma Roto / Embolización Terapéutica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aneurisma Intracraneal / Aneurisma Roto / Embolización Terapéutica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China